[시장보고서]세계의 산과 및 부인과용 초음파 장치 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 휴대성별, 최종 용도별, 지역별 부문 예측(2025-2030년)

세계의 산과 및 부인과용 초음파 장치 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 휴대성별, 최종 용도별, 지역별 부문 예측(2025-2030년)

Obstetrics & Gynecology Ultrasound Devices Market Size, Share & Trends Analysis Report By Product (2D Ultrasound, 3D/4D Ultrasound), By Portability (Cart/Trolley-Based, Portable/Handheld), By End Use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1678700

리서치사 : Grand View Research

발행일 : 2025년 02월

페이지 정보 : 영문 200 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,788,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,265,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,220,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

시장 규모와 동향

세계의 산과 및 부인과용 초음파 장치 시장 규모는 2024년 21억 3,000만 달러로 평가되었고, 2025-2030년 CAGR 4.94%를 나타낼 것으로 예측됩니다.

산과 및 부인과 초음파 장치 산업의 성장은 자궁근종, 난소낭종, 고위험 임신 등 부인과 및 산과질환의 유병률이 증가하여 조기 및 정확한 진단에 대한 수요가 높아지고 있기 때문입니다. 3D/4D 영상과 고해상도 화질 등의 기술 진보는 진단 정밀도와 태아 해부학적 구조의 가시화를 향상시키고 있습니다.

게다가 여성의료에서 첨단 진단 기술에 대한 수요가 증가함에 따라 시장의 성장이 더욱 강화되고 있습니다.

이러한 시스템을 통해 의료 전문가는 임산부의 건강 상태를 모니터링하고 평가할 수 있으며 태아 개발, 태반 건강 상태 및 잠재적 합병증에 대한 중요한 정보를 얻을 수 있습니다. 부인과 및 산과질환의 조기발견과 예방의 중요성에 대한 인식이 높아짐에 따라 영상처리능력이 향상되고 첨단기능을 갖춘 초음파 진단 시스템 수요는 증가의 길을 따라가고 있습니다. 이것은 임산부 건강 진단과 태아의 건강 모니터링을 중시하게 되어 초음파 장치가 임산부의 건강을 확보하기 위한 출생 전 스크리닝에 중요한 역할을 하게 된 것도 뒷받침되고 있습니다.

초음파 기술의 기술적 진보는 산과 및 부인과용 초음파 시스템 산업의 성장에 크게 기여하고 있습니다. 고해상도 화질, 3D/4D 영상, 고급 소프트웨어 기능 등의 혁신은 진단 정확도를 높이고 태아의 해부학적 구조와 모체의 구조를 더 잘 시각화합니다. 예를 들어, 2024년 10월, GE Healthcare는 Versana Premier 초음파 시스템을 출시했습니다. 여기에는 워크플로우, 임상 효율, 정확도를 높이는 AI 지원 도구가 포함되어 있습니다. 산과 및 부인과나 순환기과 등 다양한 전문 부문용으로 설계되어 있어 실시간으로 이미지를 최적화하는 Whizz나 AI를 활용한 라벨링 등 다양한 기능을 갖추고 있습니다. Versana Premier는 고화질 이미지를 제공하고 진단을 단순화하기 위해 노력하고 있습니다. 이러한 진화는 보다 정확하고 상세한 평가를 가능하게 하고, 이상 발견 능력을 향상시키고, 적절한 치료와 관리를 가능하게 합니다.

산과 및 부인과 초음파 장치 산업의 성장은 신흥 국가에서의 의료 지출 증가도 뒷받침하고 있으며, 새로운 병원과 의료 센터의 설립으로 이어지고 있습니다. 예를 들어, 2024년 11월, 뉴멕시코는 농촌 의료에 540만 달러를 투자할 것이라고 발표했으며, 임산부 관리에 많은 돈이 할당되었습니다. Multicultural Evaluation and Consultation Associates, LLC는 도나 아나 카운티, 카리 카운티, 리 카운티, 차베스 카운티, 퀘이 카운티, 루즈벨트 카운티의 임산부 건강 협력을 강화하기 위해 160만 달러를 받을 예정입니다. 이 이니셔티브는 고품질의 의료 접근에 농촌 지역이 직면하는 독특한 과제를 해결합니다. 이러한 임산부 관리를 위한 의료 인프라에 대한 투자와 확대는 시장 성장의 큰 기회를 창출합니다.

지역별 시장 점유율 분석, 2024년과 2030년
지역별 시장 대시보드
세계 지역 시장 현황
시장 규모, 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출기업에 의한 최근의 동향과 영향 분석
기업/경쟁의 분류
주요 기업의 시장 점유율 분석, 2024년
기업 포지션 분석
기업분류(신흥기업, 이노베이터, 리더)
기업 프로파일
- GE Healthcare
- Siemens Healthcare Private Limited
- Koninklijke Philips NV
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- FUJIFILM Corporation
- SamsungHealthcare.com
- Esaote SPA
- CANON MEDICAL SYSTEMS CORPORATION
- CHISON Medical Technologies Co., Ltd.

JHS

영문 목차

영문목차

Market Size & Trends:

The global obstetrics & gynecology ultrasound devices marketsize was estimated at USD 2.13 billion in 2024 and is projected to grow at a CAGR of 4.94% from 2025 to 2030. The growth of the obstetrics & gynecology ultrasound devices industry can be attributed to the increasing prevalence of gynecological and obstetric disorders, such as uterine fibroids, ovarian cysts, and high-risk pregnancies, creating a demand for early and accurate diagnoses. Technological advancements, such as 3D/4D imaging and high-resolution image quality, improve diagnostic accuracy and visualization of fetal anatomy.

In addition, the increasing demand for advanced diagnostic technologies in women's healthcare further fuels the market's growth.

These systems allow healthcare professionals to monitor and assess the health of pregnant women, providing crucial information on fetal development, placental health, and potential complications. As awareness grows regarding the importance of early detection and prevention of gynecological and obstetric conditions, the demand for ultrasound systems with improved imaging capabilities and advanced features continues to grow. This is further supported by the increasing emphasis on prenatal care and fetal health monitoring, with ultrasound devices playing a crucial role in prenatal screenings to ensure the well-being of pregnant women.

Technological advancements in ultrasound technology significantly contribute to the growth of the OB-GYN ultrasound systems industry. Innovations such as high-resolution image quality, 3D/4D imaging, and advanced software features enhance diagnostic accuracy and provide better visualization of fetal anatomy and maternal structures. For instance, in October 2024, GE Healthcare launched the Versana Premier ultrasound system. It offers AI-enabled tools to enhance workflow, clinical efficiency, and accuracy. It's designed for diverse specialties, such as OB-GYN and cardiology, with various features, including Whizz for real-time image optimization and AI-powered labeling. The Versana Premier provides high-quality imaging and aims for simplified diagnostics. Such advancements enable more precise and detailed assessments, improving the ability to detect abnormalities and ensure appropriate treatment and management.

The obstetrics & gynecology ultrasound devices industry growth is also fueled by the increasing healthcare expenditure in developing countries, leading to the establishment of new hospitals and medical centers. For instance, in November 2024, New Mexico announced an investment of USD 5.4 million in rural health, with significant funds allocated for maternal care. Multicultural Evaluation and Consultation Associates, LLC is expected to receive USD 1.6 million to enhance maternal health coordination in Dona Ana, Curry, Lea, Chaves, Quay, and Roosevelt counties. The initiative addresses the unique challenges faced by rural communities in accessing quality healthcare. Such investment and expansion of healthcare infrastructure for maternal care creates significant opportunities for market growth.

Global Obstetrics & Gynecology Ultrasound Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global obstetrics & gynecology ultrasound devices market report based on product, portability, end use, and region:

Product Outlook (Revenue, USD Million, 2018 - 2030)
2D Ultrasound
3D/4D Ultrasound
Doppler Ultrasound
Portability Outlook (Revenue, USD Million, 2018 - 2030)
Cart/Trolley
Portable/Handheld
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Portability
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Portability outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Obstetrics & Gynecology Ultrasound Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising birth rates & pregnancy monitoring needs
  - 3.2.1.2. Technological advancements
  - 3.2.1.3. Increasing prevalence of gynecological disorders
  - 3.2.1.4. Government & private initiatives for maternal health
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of advanced ultrasound systems
  - 3.2.2.2. Limited access in low-resource settings
  - 3.2.2.3. Stringent regulatory approvals process
3.3. Obstetrics & Gynecology Ultrasound Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Obstetrics & Gynecology Ultrasound Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Obstetrics & Gynecology Ultrasound Devices Product Market Movement Analysis
4.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. 2D Ultrasound
- 4.4.1. 2D Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.5. 3D/4D Ultrasound
- 4.5.1. 3D/4D Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Doppler Ultrasound
- 4.6.1. Doppler Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Obstetrics & Gynecology Ultrasound Devices Market: Portability Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Obstetrics & Gynecology Ultrasound Devices Portability Market Movement Analysis
5.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by Portability, 2018 to 2030 (USD Million)
5.4. Cart/Trolley
- 5.4.1. Cart/trolley market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Portable/Handheld
- 5.5.1. Portable/handheld market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Obstetrics & Gynecology Ultrasound Devices Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Obstetrics & Gynecology Ultrasound Devices End Use Market Movement Analysis
6.3. Global Obstetrics & Gynecology Ultrasound Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
- 6.5.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Obstetrics & Gynecology Ultrasound Devices Market: Regional Estimates & Trend Analysis By Product, Portability, End Use

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. U.S.
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Competitive scenario
  - 7.5.1.3. Regulatory framework
  - 7.5.1.4. Reimbursement structure
  - 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. Reimbursement structure
  - 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. Reimbursement structure
  - 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
- 7.6.1. UK
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Competitive scenario
  - 7.6.1.3. Regulatory framework
  - 7.6.1.4. Reimbursement structure
  - 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. Reimbursement structure
  - 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. Reimbursement structure
  - 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. Reimbursement structure
  - 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. Reimbursement structure
  - 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Regulatory framework
  - 7.6.6.4. Reimbursement structure
  - 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Competitive scenario
  - 7.6.7.3. Regulatory framework
  - 7.6.7.4. Reimbursement structure
  - 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Competitive scenario
  - 7.6.8.3. Regulatory framework
  - 7.6.8.4. Reimbursement structure
  - 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
- 7.7.1. Japan
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Competitive scenario
  - 7.7.1.3. Regulatory framework
  - 7.7.1.4. Reimbursement structure
  - 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Reimbursement structure
  - 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Competitive scenario
  - 7.7.3.3. Regulatory framework
  - 7.7.3.4. Reimbursement structure
  - 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Competitive scenario
  - 7.7.4.3. Regulatory framework
  - 7.7.4.4. Reimbursement structure
  - 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Competitive scenario
  - 7.7.5.3. Regulatory framework
  - 7.7.5.4. Reimbursement structure
  - 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Competitive scenario
  - 7.7.6.3. Regulatory framework
  - 7.7.6.4. Reimbursement structure
  - 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Competitive scenario
  - 7.8.1.3. Regulatory framework
  - 7.8.1.4. Reimbursement structure
  - 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Regulatory framework
  - 7.8.2.4. Reimbursement structure
  - 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
- 7.9.1. South Africa
  - 7.9.1.1. Key country dynamics
  - 7.9.1.2. Competitive scenario
  - 7.9.1.3. Regulatory framework
  - 7.9.1.4. Reimbursement structure
  - 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Competitive scenario
  - 7.9.2.3. Regulatory framework
  - 7.9.2.4. Reimbursement structure
  - 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Competitive scenario
  - 7.9.3.3. Regulatory framework
  - 7.9.3.4. Reimbursement structure
  - 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Competitive scenario
  - 7.9.4.3. Regulatory framework
  - 7.9.4.4. Reimbursement structure
  - 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
- 8.6.1. GE Healthcare
  - 8.6.1.1. Company overview
  - 8.6.1.2. Financial performance
  - 8.6.1.3. Product benchmarking
  - 8.6.1.4. Strategic initiatives
- 8.6.2. Siemens Healthcare Private Limited
  - 8.6.2.1. Company overview
  - 8.6.2.2. Financial performance
  - 8.6.2.3. Product benchmarking
  - 8.6.2.4. Strategic initiatives
- 8.6.3. Koninklijke Philips N.V.
  - 8.6.3.1. Company overview
  - 8.6.3.2. Financial performance
  - 8.6.3.3. Product benchmarking
  - 8.6.3.4. Strategic initiatives
- 8.6.4. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  - 8.6.4.1. Company overview
  - 8.6.4.2. Financial performance
  - 8.6.4.3. Product benchmarking
  - 8.6.4.4. Strategic initiatives
- 8.6.5. FUJIFILM Corporation
  - 8.6.5.1. Company overview
  - 8.6.5.2. Financial performance
  - 8.6.5.3. Product benchmarking
  - 8.6.5.4. Strategic initiatives
- 8.6.6. SamsungHealthcare.com
  - 8.6.6.1. Company overview
  - 8.6.6.2. Financial performance
  - 8.6.6.3. Product benchmarking
  - 8.6.6.4. Strategic initiatives
- 8.6.7. Esaote SPA
  - 8.6.7.1. Company overview
  - 8.6.7.2. Financial performance
  - 8.6.7.3. Product benchmarking
  - 8.6.7.4. Strategic initiatives
- 8.6.8. CANON MEDICAL SYSTEMS CORPORATION
  - 8.6.8.1. Company overview
  - 8.6.8.2. Financial performance
  - 8.6.8.3. Product benchmarking
  - 8.6.8.4. Strategic initiatives
- 8.6.9. CHISON Medical Technologies Co., Ltd.
  - 8.6.9.1. Company overview
  - 8.6.9.2. Financial performance
  - 8.6.9.3. Product benchmarking
  - 8.6.9.4. Strategic initiatives

한글목차

시장 규모와 동향

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 산과 및 부인과용 초음파 장치 시장의 변수, 동향, 범위

제4장 산과 및 부인과용 초음파 장치 시장 : 제품별, 추정 및 동향 분석

제5장 산과 및 부인과용 초음파 장치 시장 : 휴대성별, 추정 및 동향 분석

제6장 산과 및 부인과용 초음파 장치 시장 : 최종 용도별, 추정 및 동향 분석

제7장 산과 및 부인과용 초음파 장치 시장 : 제품, 휴대성, 최종 용도에 의한 지역별, 추정 및 동향 분석